Cytophage Develops Freeze-Dried Phage Tablets For Poultry
Cytophage Technologies (TSXV: CYTO) has announced the launch of a new product that it believes will set itself apart within the phage industry globally.
Read more
Cytophage Technologies
Phage Therapy’s Rising Demand: Cytophage at the Forefront with Dr. Steven Theriault
In this interview, Dr. Steven Theriault, CEO of Cytophage Technologies Ltd. (TSXV:CYTO), presents phage therapy as a potentially revolutionary biotech solution. He illustrates its efficacy by citing a successful treatment of a severe infection in Ottawa, underscoring the increasing demand for alternative treatments to combat antibiotic resistance.
Read more
Cytophage Enters Letter Of Intent With Major Singapore-Based Agrifood Company
Cytophage Technologies (TSXV: CYTO) is focusing its efforts on expanding the commercialization of its phage products within the Asian poultry market.
Read more
Cytophage Adds 30-Year Biotech Exec To Its Board
Cytophage Technologies (TSXV: CYTO) has added bench strength to its board of directors this morning, adding a thirty year pharmaceutical and biotech executive to its board.
Read more
Cytophage To Focus On Commercialization Efforts In 2024
Cytophage Technologies (TSXV: CYTO) has filed its fiscal 2023 results, providing a recap on a successful year in terms of corporate development while providing an outline of where the company is headed in 2024.
Read more
Cytophage: Landmark Phage Therapy Saves Ottawa Woman From Life-Threatening Infection
A 79-year-old resident from the Ottawa area credits an experimental treatment developed in Winnipeg with saving her life from a chronic artificial joint infection.
Read more
Cytophage Reports Early Success In Single Subject Clinical Trial
Cytophage Technologies (TSXV: CYTO) has seen early success in a recently completed human trial conducted at The Ottawa Hospital. The trial, which saw the use of its phages for the treatment of an antibiotic-resistant prosthetic joint infection, was the first time in Canada that phages were used for the treatment of a joint replacement infection.
Read more
Cytophage Sees Its Bacteriophages Used As Treatment In Canada Under Single Subject Clinical Trial
For the first time in Canadian history, bacteriophage therapy is slated to be utilized to assist a patient suffering from a severe bone and joint infection related to a prosthetic.
Read more
The Solution To Antibiotic Resistance – With Cytophage CEO Dr Steven Theriault
FULL DISCLOSURE: This is sponsored content for Cytophage Technologies. In this interview, Dr. Steven Theriault BSc, MSc, PhD, CEO of
Read more